Investment
Anticipating a Series A round in Q2 2025
Limula is seeking conversations with Series A investors, to establish relationships and build trust ahead of the next financing round.
- Early stage.
- Biotech and Pharma
Author
Limula is a Life Science Tools company based in Lausanne, Switzerland, addressing a key bottleneck of one of the fastest growing therapeutic modality: Cell & Gene Therapy. Limula proprietary technology enables on-demand and at-scale manufacturing of highly-personalised treatments in a single device, using end-to-end automation and integrated process analytics.
Sectors
Investment
Anticipating a Series A round in Q2 2025
Limula is seeking conversations with Series A investors, to establish relationships and build trust ahead of the next financing round.